BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct-acting antivirals
1
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
1/23/2024 9:31:45 AM | Browse: 197 | Download: 633
2
Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
12/2/2022 9:49:51 AM | Browse: 453 | Download: 1048
3
Hepatitis C virus burden: Treating and educating people without prejudice
7/27/2022 1:17:38 PM | Browse: 453 | Download: 1295
4
Fibrosis regression following hepatitis C antiviral therapy
6/23/2022 2:39:01 PM | Browse: 489 | Download: 1269
5
Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection
6/23/2022 2:39:01 PM | Browse: 463 | Download: 868
6
Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
6/10/2022 5:40:20 AM | Browse: 549 | Download: 1126
7
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
1/11/2022 8:34:26 AM | Browse: 519 | Download: 1382
8
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan
9/29/2021 11:12:00 AM | Browse: 520 | Download: 1296
9
Planning the hepatitis C virus elimination in Cyprus: A modeling study
8/18/2021 8:08:20 AM | Browse: 536 | Download: 1389
10
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
8/4/2021 7:56:20 AM | Browse: 609 | Download: 1438
11
Towards a new era of hepatitis B virus therapeutics: The pursuit of functional cure
5/27/2021 9:41:33 AM | Browse: 576 | Download: 1272
12
Viral hepatitis: A brief introduction, review of management, advances and challenges
4/28/2021 12:31:49 PM | Browse: 596 | Download: 973
13
Genotype 3-hepatitis C virus’ last line of defense
3/17/2021 6:19:34 AM | Browse: 722 | Download: 1643
14
Facial and bilateral lower extremity edema due to drug-drug interactions in a patient with hepatitis C virus infection and benign prostate hypertrophy: A case report
8/6/2020 9:52:06 AM | Browse: 806 | Download: 1816
15
Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
8/7/2019 7:09:17 AM | Browse: 1054 | Download: 1848
16
Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
4/26/2019 3:40:00 AM | Browse: 1108 | Download: 1899
17
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
10/27/2018 4:40:10 AM | Browse: 1087 | Download: 2221
18
Challenge to overcome: Nonstructural protein 5A-P32 deletion in direct-acting antiviral-based therapy for hepatitis C virus
10/12/2018 5:32:21 AM | Browse: 809 | Download: 1261
19
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 1153 | Download: 2024
20
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 1385 | Download: 2257
21
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience
1/26/2018 8:09:36 AM | Browse: 1089 | Download: 2033
22
Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
12/27/2017 10:31:19 AM | Browse: 1164 | Download: 2071
23
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
12/5/2017 1:55:00 AM | Browse: 1112 | Download: 2027
24
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 1374 | Download: 2945
25
Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
6/26/2017 10:23:05 AM | Browse: 1079 | Download: 1720
26
Is it enough to eliminate hepatitis C virus to reverse the damage caused by the infection?
2/24/2017 9:02:00 AM | Browse: 1011 | Download: 1619
27
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
7/29/2016 8:32:00 PM | Browse: 1198 | Download: 1800
28
Hepatitis C virus genotypes in Myanmar
7/15/2016 3:38:00 PM | Browse: 1120 | Download: 1956
29
Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?
4/19/2016 2:32:00 PM | Browse: 1415 | Download: 1624
30
Update on hepatitis C: Direct-acting antivirals
12/4/2015 3:24:00 PM | Browse: 1208 | Download: 2017
31
Hepatitis C virus: A global view
11/18/2015 11:12:00 AM | Browse: 1432 | Download: 1746
32
Hepatitis C virus infection: Are there still specific problems with genotype 3?
11/11/2015 1:33:00 PM | Browse: 1415 | Download: 2154
33
Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
10/14/2015 12:06:00 PM | Browse: 1078 | Download: 2061
34
Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments
9/9/2015 2:44:00 PM | Browse: 1224 | Download: 2005
35
New treatment strategies for hepatitis C infection
8/21/2015 1:38:00 PM | Browse: 1317 | Download: 1979
36
Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade
4/19/2015 5:46:00 PM | Browse: 1622 | Download: 1761
37
Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control
3/30/2015 5:46:00 PM | Browse: 1367 | Download: 2213
38
Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6
3/13/2015 3:29:00 PM | Browse: 1326 | Download: 1781
39
Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy
8/25/2014 2:47:00 PM | Browse: 1221 | Download: 993